Ikris Pharma International (IPI) facilitates researchers/CRO/Pharmaceutical Companies in accessing products which are not available or approved in their country. Such organization requires comparator drugs for their bioequivalence or bioavailability (BE/BA) Studies. Our experience combined with our network of RLD wholesaler/ distributors makes it possible for IPI to procure branded Innovator Samples/Reference Listed Drugs for BE/BA Studies and clinical trials from most of the reference countries. Be it from USA, EU, Japan or Australia. These medicines are mostly US FDA /EMEA approved medicine. IPI specializes in sourcing branded Innovator Samples/Reference Listed Drugs (RLD) from single/multiple batches in specific quantities as well as products that are unavailable from most suppliers.
Our experience with cold chain shipping and in dealing with international customs requirements helps us to ensure that temperature sensitive study drugs arrive to your clinical trial facilities within the required temperature range. We use dedicated transport companies that cater for cold, ambient and everyday storage and delivery requirements.
Our team will provide regular updates and advise of product shortages or manufacturer delays enabling you to stay one step ahead and plan your study accordingly.